These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 25385716)

  • 1. Biomimetic 3D Tissue Models for Advanced High-Throughput Drug Screening.
    Nam KH; Smith AS; Lone S; Kwon S; Kim DH
    J Lab Autom; 2015 Jun; 20(3):201-15. PubMed ID: 25385716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomimetic cardiac microsystems for pathophysiological studies and drug screens.
    Lee J; Razu ME; Wang X; Lacerda C; Kim JJ
    J Lab Autom; 2015 Apr; 20(2):96-106. PubMed ID: 25524490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-Engineered 3D In Vitro Disease Models for High-Throughput Drug Screening.
    Huskin G; Chen J; Davis T; Jun HW
    Tissue Eng Regen Med; 2023 Jul; 20(4):523-538. PubMed ID: 36892736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D Engineering of Ocular Tissues for Disease Modeling and Drug Testing.
    Boutin ME; Hampton C; Quinn R; Ferrer M; Song MJ
    Adv Exp Med Biol; 2019; 1186():171-193. PubMed ID: 31654390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening.
    Dautriche CN; Szymanski D; Kerr M; Torrejon KY; Bergkvist M; Xie Y; Danias J; Stamer WD; Sharfstein ST
    Biomaterials; 2015 Oct; 65():86-92. PubMed ID: 26142779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrated biomimetic array chip for high-throughput co-culture of liver and tumor microtissues for advanced anticancer bioactivity screening.
    Hou Y; Ai X; Zhao L; Gao Z; Wang Y; Lu Y; Tu P; Jiang Y
    Lab Chip; 2020 Jul; 20(14):2482-2494. PubMed ID: 32542294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D liver models on a microplatform: well-defined culture, engineering of liver tissue and liver-on-a-chip.
    Yoon No D; Lee KH; Lee J; Lee SH
    Lab Chip; 2015 Oct; 15(19):3822-37. PubMed ID: 26279012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel hanging spherical drop system for the generation of cellular spheroids and high throughput combinatorial drug screening.
    Neto AI; Correia CR; Oliveira MB; Rial-Hermida MI; Alvarez-Lorenzo C; Reis RL; Mano JF
    Biomater Sci; 2015 Apr; 3(4):581-5. PubMed ID: 26222417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering three-dimensional cardiac microtissues for potential drug screening applications.
    Wang L; Huang G; Sha B; Wang S; Han YL; Wu J; Li Y; Du Y; Lu TJ; Xu F
    Curr Med Chem; 2014; 21(22):2497-509. PubMed ID: 24358973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensionally engineered biomimetic tissue models for in vitro drug evaluation: delivery, efficacy and toxicity.
    Peck Y; Wang DA
    Expert Opin Drug Deliv; 2013 Mar; 10(3):369-83. PubMed ID: 23289593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microengineered liver tissues for drug testing.
    Khetani SR; Berger DR; Ballinger KR; Davidson MD; Lin C; Ware BR
    J Lab Autom; 2015 Jun; 20(3):216-50. PubMed ID: 25617027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superhydrophobic chips for cell spheroids high-throughput generation and drug screening.
    Oliveira MB; Neto AI; Correia CR; Rial-Hermida MI; Alvarez-Lorenzo C; Mano JF
    ACS Appl Mater Interfaces; 2014 Jun; 6(12):9488-95. PubMed ID: 24865973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microtechnology-based organ systems and whole-body models for drug screening.
    Lee SH; Ha SK; Choi I; Choi N; Park TH; Sung JH
    Biotechnol J; 2016 Jun; 11(6):746-56. PubMed ID: 27125245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-Based Assays on Microfluidics for Drug Screening.
    Liu X; Zheng W; Jiang X
    ACS Sens; 2019 Jun; 4(6):1465-1475. PubMed ID: 31074263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D in vitro tissue models and their potential for drug screening.
    Kimlin L; Kassis J; Virador V
    Expert Opin Drug Discov; 2013 Dec; 8(12):1455-66. PubMed ID: 24144315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microengineered Organ-on-a-chip Platforms towards Personalized Medicine.
    Kankala RK; Wang SB; Chen AZ
    Curr Pharm Des; 2018; 24(45):5354-5366. PubMed ID: 30799783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioprinting towards Physiologically Relevant Tissue Models for Pharmaceutics.
    Peng W; Unutmaz D; Ozbolat IT
    Trends Biotechnol; 2016 Sep; 34(9):722-732. PubMed ID: 27296078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D Bioprinting of Tissue/Organ Models.
    Pati F; Gantelius J; Svahn HA
    Angew Chem Int Ed Engl; 2016 Apr; 55(15):4650-65. PubMed ID: 26895542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 3D biomimetic model of tissue stiffness interface for cancer drug testing.
    Lam CR; Wong HK; Nai S; Chua CK; Tan NS; Tan LP
    Mol Pharm; 2014 Jul; 11(7):2016-21. PubMed ID: 24754837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microprinting of liver micro-organ for drug metabolism study.
    Chang RC; Emami K; Jeevarajan A; Wu H; Sun W
    Methods Mol Biol; 2011; 671():219-38. PubMed ID: 20967633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.